×
About 1,625 results

ALLMedicine™ Insulin Pumps Center

Research & Reviews  645 results

Pump It Up! A randomized clinical trial to optimize insulin pump self-management behavi...
https://doi.org/10.1016/j.cct.2021.106279
Contemporary Clinical Trials; O'Donnell HK, Vigers T et. al.

Jan 13th, 2021 - Individuals with type 1 diabetes (T1D) must engage in a variety of complex and burdensome self-management behaviors daily to maintain near normal blood glucose levels and prevent complications. There is a need for interventions to improve use of s...

In Children and Young people with type 1 Diabetes using Pump Therapy an additional 40% ...
https://doi.org/10.1111/dme.14511
Diabetic Medicine : a Journal of the British Diabetic Association; Smith TA, Smart CE et. al.

Jan 6th, 2021 - To determine the insulin requirement for a high fat, high protein breakfast to optimise postprandial glycaemic excursions in children and young people with type 1 diabetes using insulin pumps. Twenty-seven participants age 10-23 years, BMI <95th p...

Predictors of the maximal oxygen consumption in adult patients with type 1 diabetes tre...
https://doi.org/10.1111/jdi.13490
Journal of Diabetes Investigation; Matejko B, Tota Ł et. al.

Dec 30th, 2020 - Regular physical activity for adults with type 1 diabetes (T1DM) improves cardiorespiratory fitness (CF) and quality of life. The aim of our study was to evaluate clinical and biochemical features that may be associated with CF in a homogenous gro...

Pregnancy and type 1 diabetes: updates on technology and treatment.
https://doi.org/10.1097/MED.0000000000000605
Current Opinion in Endocrinology, Diabetes, and Obesity; Kennedy-Grant A, Golden L

Dec 28th, 2020 - The goal of this article is to review recent research of technology use, including insulin pumps, continuous glucose monitors, and smartpens, for pregnant women with preexisting type 1 diabetes. Recent research shows that there may be benefits fro...

Less nocturnal hypoglycemia but equivalent time in range among adults with type 1 diabe...
https://doi.org/10.1089/dia.2020.0589
Diabetes Technology & Therapeutics; McAuley SA, Vogrin S et. al.

Dec 22nd, 2020 - Background This pre-randomization analysis from the Australian HCL-Adult trial compared masked continuous glucose monitoring (CGM) metrics among adults using insulin pumps versus multiple daily injections (MDI), who were all self-monitoring blood ...

see more →

Guidelines  7 results

A Type 1 diabetes technology pathway: consensus statement for the use of technology in ...
https://doi.org/10.1111/dme.13933
Diabetic Medicine : a Journal of the British Diabetic Association; Choudhary P, Campbell F et. al.

Feb 18th, 2019 - In both adults and children with diabetes, technologies such as continuous subcutaneous insulin infusion using insulin pumps and continuous glucose monitoring can help improve diabetes control, reduce hypoglycaemia and improve quality of life. Acc...

Diabetes Technology: Standards of Medical Care in Diabetes—2019
http://care.diabetesjournals.org/content/42/Supplement_1/S71

Dec 17th, 2018 - Diabetes technology is the term used to describe the hardware, devices, and software that people with diabetes use to help manage blood glucose levels, stave off diabetes complications, reduce the burden of living with diabetes, and improve qualit...

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY...
https://doi.org/10.4158/PS-2017-0155
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists; Grunberger G, Handelsman Y et. al.

Mar 16th, 2018 - This document represents the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there are no randomized controlled trials or specific U.S. FDA labeling for issues in clinical pra...

JDRF Statement: Animas Exits the Insulin Pump Business - Guideline
http://www.jdrf.org/blog/2017/10/05/jdrf-statement-animas-exits-the-insulin-pump-business/
Juvenile Diabetes Research Foundation International

Oct 4th, 2017 - The choice of a pump should be made by people with diabetes and their doctors, and JDRF does not endorse products. For those Animas customers needing a new pump, the following links might be helpful.

see more →

Drugs  1 results see all →

Clinicaltrials.gov  783 results

Pump It Up! A randomized clinical trial to optimize insulin pump self-management behavi...
https://doi.org/10.1016/j.cct.2021.106279
Contemporary Clinical Trials; O'Donnell HK, Vigers T et. al.

Jan 13th, 2021 - Individuals with type 1 diabetes (T1D) must engage in a variety of complex and burdensome self-management behaviors daily to maintain near normal blood glucose levels and prevent complications. There is a need for interventions to improve use of s...

In Children and Young people with type 1 Diabetes using Pump Therapy an additional 40% ...
https://doi.org/10.1111/dme.14511
Diabetic Medicine : a Journal of the British Diabetic Association; Smith TA, Smart CE et. al.

Jan 6th, 2021 - To determine the insulin requirement for a high fat, high protein breakfast to optimise postprandial glycaemic excursions in children and young people with type 1 diabetes using insulin pumps. Twenty-seven participants age 10-23 years, BMI <95th p...

Predictors of the maximal oxygen consumption in adult patients with type 1 diabetes tre...
https://doi.org/10.1111/jdi.13490
Journal of Diabetes Investigation; Matejko B, Tota Ł et. al.

Dec 30th, 2020 - Regular physical activity for adults with type 1 diabetes (T1DM) improves cardiorespiratory fitness (CF) and quality of life. The aim of our study was to evaluate clinical and biochemical features that may be associated with CF in a homogenous gro...

Pregnancy and type 1 diabetes: updates on technology and treatment.
https://doi.org/10.1097/MED.0000000000000605
Current Opinion in Endocrinology, Diabetes, and Obesity; Kennedy-Grant A, Golden L

Dec 28th, 2020 - The goal of this article is to review recent research of technology use, including insulin pumps, continuous glucose monitors, and smartpens, for pregnant women with preexisting type 1 diabetes. Recent research shows that there may be benefits fro...

Less nocturnal hypoglycemia but equivalent time in range among adults with type 1 diabe...
https://doi.org/10.1089/dia.2020.0589
Diabetes Technology & Therapeutics; McAuley SA, Vogrin S et. al.

Dec 22nd, 2020 - Background This pre-randomization analysis from the Australian HCL-Adult trial compared masked continuous glucose monitoring (CGM) metrics among adults using insulin pumps versus multiple daily injections (MDI), who were all self-monitoring blood ...

see more →

News  189 results

Insulin Pumps Used Less in Black Children, Even With Insurance
https://www.staging.medscape.com/viewarticle/937167

Sep 9th, 2020 - Black children with type 1 diabetes in the United States are far less likely than white children to be prescribed insulin pumps, even among those with private health insurance, new research suggests. The data were published online September 1 in t...

Insulin Pumps Used Less in Black Children, Even With Insurance
https://www.medscape.com/viewarticle/937167

Sep 9th, 2020 - Black children with type 1 diabetes in the United States are far less likely than white children to be prescribed insulin pumps, even among those with private health insurance, new research suggests. The data were published online September 1 in t...

In Medicare, Insulin Costs More for Patients Who Use Pumps
https://www.medscape.com/viewarticle/936734

Sep 1st, 2020 - Under the US Medicare system, the cost of insulin is about 50% higher for beneficiaries who use insulin pumps than those who inject insulin, a new analysis reveals.   The issue was outlined, along with a "call to action", in a commentary recently ...

Medtronic Recalls MiniMed Insulin Pumps for Incorrect Insulin Dosing | FDA
https://www.fda.gov/medical-devices/medical-device-recalls/medtronic-recalls-minimed-insulin-pumps-incorrect-insulin-dosing

The FDA has identified this as a Class I recall, the most serious type of recall.  Use of these devices may cause serious injuries or death. Recalled Product MiniMed 600 Series Insulin Pumps Model 630G (MMT-1715) - all lots before October 2019 Mod...

FDA Issues MiniMed600 Insulin Pump Recall
https://www.staging.medscape.com/viewarticle/925194

Feb 12th, 2020 - Medtronic is recalling certain MiniMed600 insulin pumps as part of a class I recall, the most serious kind of recall, because of a potentially fatal risk of incorrect dosing, according to a Food and Drug Administration MedWatch release. A class I ...

see more →